Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies
Clinical trial NCT05226871 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05226871
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-07
- Primary completion
- 2026-12-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.